Skip to main content
Erschienen in: Journal of Cancer Survivorship 2/2023

20.06.2022

Assessing the impact of religious resources and struggle on well-being: a report from the American Cancer Society’s Study of Cancer Survivors-I

verfasst von: Andrea L. Canada, Patricia E. Murphy, Kevin Stein, Kassandra I. Alcaraz, Corinne R. Leach, George Fitchett

Erschienen in: Journal of Cancer Survivorship | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The current study examined the relationships between religious resources (i.e., certainty of belief in God and attendance at religious services), religious struggle (e.g., belief that cancer is evidence of God’s punishment or abandonment), and physical and mental health-related quality of life (HRQoL), including fear of cancer recurrence (FCR), in a large, geographically and clinically diverse sample of long-term survivors of cancer.

Methods

Participants were 2021 9-year survivors of cancer from the American Cancer Society’s Study of Cancer Survivors – I. Religious resources included belief in God and attendance at religious services. Items from the Brief RCOPE and the PROMIS Psychosocial Impact of Illness were combined to assess religious struggle. Survivors also completed the Fear of Cancer Recurrence Inventory, SF-12, and Meaning and Peace subscales of the FACIT-Sp. Regression models were used to predict HRQoL and FCR from religious resources and struggle.

Results

In multivariable models, certain belief in God predicted greater mental HRQoL (B = 1.99, p < .01), and attendance at religious services was associated with greater FCR (B = .80, p < .05) as well as better mental (B = .34, p < .01) and physical (B = .29, p < .05) HRQoL. In addition, religious struggle predicted greater FCR (B = 1.32, p < .001) and poorer mental (B =  − .59, p < .001) and physical (B =  − .29, p < .001) HRQoL. Many of these relationships were mediated through Meaning.

Conclusions

With the exception of FCR, religious resources predicted better HRQoL outcomes in these long-term survivors of cancer. Conversely, religious struggle consistently predicted poorer HRQoL, including greater FCR.

Implications for Cancer Survivors

Given the documented importance of its role in coping with the cancer experience, religion/spirituality should be a consideration in every survivorship care plan. Multidisciplinary assessment and support of religious resources and identification of and referral for religious struggle are needed to ensure the well-being of most long-term survivors of cancer.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
18.
29.
Zurück zum Zitat Fetzer Institute/National Institute on Aging Working Group. Multidimensional measure of religiousness/spirituality for use in health research. Kalamazoo, MI: Fetzer Institute; 1999. Fetzer Institute/National Institute on Aging Working Group. Multidimensional measure of religiousness/spirituality for use in health research. Kalamazoo, MI: Fetzer Institute; 1999.
32.
Zurück zum Zitat Murphy PE, Canada AL, Fitchett G, et al. An examination of the 3-factor model and structural invariance across racial/ethnic groups for the FACIT-Sp: a report from the American Cancer Society’s Study of Cancer Survivors-II (SCS-II). Psychooncology. 2010;19:264–72. https://doi.org/10.1002/pon.1559.CrossRefPubMed Murphy PE, Canada AL, Fitchett G, et al. An examination of the 3-factor model and structural invariance across racial/ethnic groups for the FACIT-Sp: a report from the American Cancer Society’s Study of Cancer Survivors-II (SCS-II). Psychooncology. 2010;19:264–72. https://​doi.​org/​10.​1002/​pon.​1559.CrossRefPubMed
35.
Zurück zum Zitat Hayes AF. Introduction to mediation, moderation, and conditional process analysis: A regression-based approach. 2nd ed. New York: The Guilford Press; 2018. Hayes AF. Introduction to mediation, moderation, and conditional process analysis: A regression-based approach. 2nd ed. New York: The Guilford Press; 2018.
50.
Zurück zum Zitat Park CL. Religion and meaning. In: Paloutzian RF, Park CL, editors. Handbook of the Psychology of Religion and Spirituality. New York, NY: The Guilford Press; 2005. p. 295–314. Park CL. Religion and meaning. In: Paloutzian RF, Park CL, editors. Handbook of the Psychology of Religion and Spirituality. New York, NY: The Guilford Press; 2005. p. 295–314.
Metadaten
Titel
Assessing the impact of religious resources and struggle on well-being: a report from the American Cancer Society’s Study of Cancer Survivors-I
verfasst von
Andrea L. Canada
Patricia E. Murphy
Kevin Stein
Kassandra I. Alcaraz
Corinne R. Leach
George Fitchett
Publikationsdatum
20.06.2022
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 2/2023
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-022-01226-8

Weitere Artikel der Ausgabe 2/2023

Journal of Cancer Survivorship 2/2023 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.